Islam Mohammad Mirazul, Saha Amrita, Trisha Farzana Afrose, Gonzalez-Andrades Miguel, Patra Hirak K, Griffith May, Chodosh James, Rajaiya Jaya
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear and Schepens Eye Research Institute, Boston, Massachusetts.
Department of Ophthalmology and Visual Sciences, University of New Mexico School of Medicine, Albuquerque, New Mexico.
Ophthalmol Sci. 2024 May 6;4(6):100544. doi: 10.1016/j.xops.2024.100544. eCollection 2024 Nov-Dec.
To develop a 3-dimensional corneal construct suitable for in vitro studies of disease conditions and therapies.
In vitro human corneal constructs were created using chemically crosslinked collagen and chondroitin sulfate extracellular matrix and seeded with 3 human corneal cell types (epithelial, stromal, and endothelial) together with neural cells. The neural cells were derived from hybrid neuroblastoma cells and the other cells used from immortalized human corneal cell lines. To check the feasibility and characterize the constructs, cytotoxicity, cell proliferation, histology, and protein expression studies were performed.
Optimized culture condition permitted synchronized viability across the cell types within the construct. The construct showed a typical appearance for different cellular layers, including healthy appearing, phenotypically differentiated neurons. The expected protein expression profiles for specific cell types within the construct were confirmed with western blotting.
An in vitro corneal construct was successfully developed with maintenance of individual cell phenotypes with anatomically correct cellular loci. The construct may be useful in evaluation of specific corneal disorders and in developing different corneal disease models. Additionally, the construct can be used in evaluating drug targeting and/or penetration to individual corneal layers, testing novel therapeutics for corneal diseases, and potentially reducing the necessity for animals in corneal research at the early stages of investigation.
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
构建一种适用于疾病状况和治疗体外研究的三维角膜结构。
使用化学交联的胶原蛋白和硫酸软骨素细胞外基质创建体外人角膜结构,并接种3种人角膜细胞类型(上皮细胞、基质细胞和内皮细胞)以及神经细胞。神经细胞来源于杂交神经母细胞瘤细胞,其他细胞则取自永生化人角膜细胞系。为检验该结构的可行性并对其进行表征,开展了细胞毒性、细胞增殖、组织学和蛋白质表达研究。
优化的培养条件使结构内各细胞类型的活力得以同步维持。该结构呈现出不同细胞层的典型外观,包括外观健康、表型分化的神经元。通过蛋白质免疫印迹法证实了结构内特定细胞类型的预期蛋白质表达谱。
成功开发出一种体外角膜结构,其维持了各个细胞表型以及解剖学上正确的细胞定位。该结构可能有助于评估特定的角膜疾病以及开发不同的角膜疾病模型。此外,该结构可用于评估药物对各个角膜层的靶向作用和/或渗透情况,测试角膜疾病的新型治疗方法,并有可能在研究的早期阶段减少角膜研究中对动物的需求。
本文末尾的脚注和披露中可能包含专有或商业披露信息。